| Use of oral antidiabetic drugs in Japanese working-age patients with type 2 diabetes mellitus: dosing pattern for metformin initiators T Kameda, H Kumamaru, S Nishimura, S Kohsaka, H Miyata Current Medical Research and Opinion 36 (5), 749-756, 2020 | 21 | 2020 |
| Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan S Nishimura, H Kumamaru, S Shoji, M Sawano, S Kohsaka, H Miyata Hypertension Research 43 (7), 705-714, 2020 | 17 | 2020 |
| Assessment of coding-based frailty algorithms for long-term outcome prediction among older people in community settings: a cohort study from the Shizuoka Kokuho Database S Nishimura, H Kumamaru, S Shoji, E Nakatani, H Yamamoto, N Ichihara, ... Age and Ageing 51 (3), afac009, 2022 | 14 | 2022 |
| Changes in the characteristics and initial treatments of pulmonary hypertension between 2008 and 2020 in Japan Y Tamura, H Kumamaru, T Inami, H Matsubara, K Hirata, I Tsujino, ... JACC: Asia 2 (3_Part_1), 273-284, 2022 | 11 | 2022 |
| Incidence of adverse cardiovascular events in type 2 diabetes mellitus patients after initiation of glucose‐lowering agents: A population‐based community study from the … S Kohsaka, H Kumamaru, S Nishimura, S Shoji, E Nakatani, N Ichihara, ... Journal of Diabetes Investigation 12 (8), 1452-1461, 2021 | 11 | 2021 |
| Real-world evidence of the incidence of and risk factors for type 1 diabetes mellitus and hypothyroidism as immune-related adverse events associated with programmed cell death … K Shimada, H Yamamoto, E Nakatani, H Kumamaru, S Nishimura, ... Endocrine Practice 27 (6), 586-593, 2021 | 7 | 2021 |
| Initial Triple Combination Therapy Including Intravenous Prostaglandin I2 for the Treatment of Patients with Severe Pulmonary Arterial Hypertension Insights from Real-World … Y Tamura, H Kumamaru, S Nishimura, Y Nakajima, H Matsubara, ... International Heart Journal 64 (4), 684-692, 2023 | 3 | 2023 |
| Cost reduction associated with transradial access in percutaneous coronary intervention: A report from a Japanese nationwide registry S Shoji, S Kohsaka, H Kumamaru, K Yamaji, S Nishimura, H Ishii, ... The Lancet Regional Health–Western Pacific 28, 2022 | 3 | 2022 |
| Risk prediction models in patients undergoing percutaneous coronary intervention: A collaborative analysis from a Japanese administrative dataset and nationwide academic … S Shoji, S Kohsaka, H Kumamaru, S Nishimura, H Ishii, T Amano, ... International Journal of Cardiology 370, 90-97, 2023 | 2 | 2023 |
| Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study S Nishimura, H Kumamaru, S Shoji, E Nakatani, H Yamamoto, N Ichihara, ... Research and Practice in Thrombosis and Haemostasis 7 (3), 100129, 2023 | 1 | 2023 |
| Persistence of tolvaptan medication for autosomal dominant polycystic kidney disease: A retrospective cohort study using Shizuoka Kokuho Database R Saito, H Yamamoto, N Ichihara, H Kumamaru, S Nishimura, K Shimada, ... Medicine 101 (40), e30923, 2022 | | 2022 |
| ASSOCIATION OF FRAILTY WITH LONG-TERM STROKE AND BLEEDING RISK IN OLDER PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE SHIZUOKA STUDY S Nishimura, H Kumamaru, S Shoji, E Nakatani, H Yamamoto, N Ichihara, ... Journal of the American College of Cardiology 79 (9_Supplement), 1139-1139, 2022 | | 2022 |
| Incidence of Heart Failure Hospital Admissions Among Type 2 Diabetes Mellitus Patients and the Potential Impact of SGLT2 Inhibitors in Japan: A Population-based Study From the … S Nishimura, H Kumamaru, S Kohsaka, S Shoji, E Nakatani, H Yamamoto, ... Circulation 142 (Suppl_3), A13289-A13289, 2020 | | 2020 |
